Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline
PUBLISHED Tuesday, April 28, 2026 · onco3r therapeutics bv
AI BRIEFING
- ⬤ Coultreon Biopharma raises $125M in Series A financing
- ⬤ Led by Sofinnova Investments, with Forbion and Novo Holdings as co-leads
- ⬤ To advance immunology pipeline
ADVERTISEMENT